143 related articles for article (PubMed ID: 31693509)
1. Prognostic Significance of Nuclear Factor Kappa B Expression in Locally Advanced Cervical Cancer Patients Treated Definitively With Concurrent Chemoradiation.
Altoos B; Small C; Dalal P; Attieh D; El Achy S; Parimi V; Wei JJ; Helenowski I; Donnelly ED; Strauss J; Small W; Refaat T
Am J Clin Oncol; 2020 Jan; 43(1):47-51. PubMed ID: 31693509
[TBL] [Abstract][Full Text] [Related]
2. Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy.
Gaber G; El Achy S; Khedr GA; Parimi V; Helenowksi I; Donnelly ED; Strauss JB; Woloschak G; Wei JJ; Small W; Refaat T
Am J Clin Oncol; 2021 Feb; 44(2):58-67. PubMed ID: 33284239
[TBL] [Abstract][Full Text] [Related]
3. c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.
Refaat T; Donnelly ED; Sachdev S; Parimi V; El Achy S; Dalal P; Farouk M; Berg N; Helenowski I; Gross JP; Lurain J; Strauss JB; Woloschak G; Wei JJ; Small W
Am J Clin Oncol; 2017 Dec; 40(6):590-597. PubMed ID: 26083558
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
Hu K; Wang W; Liu X; Meng Q; Zhang F
Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
[TBL] [Abstract][Full Text] [Related]
5. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
[TBL] [Abstract][Full Text] [Related]
6. Nuclear NF-κB expression correlates with outcome among patients with head and neck squamous cell carcinoma treated with primary chemoradiation therapy.
Balermpas P; Michel Y; Wagenblast J; Seitz O; Sipek F; Rödel F; Rödel C; Fokas E
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):785-90. PubMed ID: 23664323
[TBL] [Abstract][Full Text] [Related]
7. Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.
Manders DB; Morón A; McIntire D; Miller DS; Richardson DL; Kehoe SM; Albuquerque KV; Lea JS
Am J Clin Oncol; 2018 May; 41(5):447-451. PubMed ID: 27258678
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
[No Abstract] [Full Text] [Related]
9. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B
Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
[TBL] [Abstract][Full Text] [Related]
11. Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation.
Garg AK; Jhingran A; Klopp AH; Aggarwal BB; Kunnumakkara AB; Broadus RR; Eifel PJ; Buchholz TA
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1331-6. PubMed ID: 20231067
[TBL] [Abstract][Full Text] [Related]
12. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
13. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
14. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Standardized Intratumoral Metabolic Heterogeneity in Locally Advanced Cervical Cancer Treated With Chemoradiation.
Yang F; Young L; Grigsby P
Int J Gynecol Cancer; 2016 May; 26(4):777-84. PubMed ID: 27101524
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
[TBL] [Abstract][Full Text] [Related]
18. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]